Halofuginone hydrobromide
Cat. No.:YN450145
| 产品名称: | Halofuginone hydrobromide | 
| CAS No.: | 64924-67-0 | 
| Chemical Name: | rel-7-Bromo-6-chloro-3-[3-[(2R,3S)-3-hydroxy-2-piperidinyl]-2-oxopropyl]-4(3H)-quinazolinone Hydrobromide; trans-(+/-)-7-Bromo-6-chloro-3-[3-(3-hydroxy-2- | 
| Synonyms: | 常山酮溴酸盐; RU-19110 hydrobromide | 
| 分子量: | 495.59 | 
| 分子式: | C₁₆H₁₈Br₂ClN₃O₃ | 
| SMILES: | O=C1N(CC(C[C@@H]2NCCC[C@H]2O)=O)C=NC3=C1C=C(Cl)C(Br)=C3.Br | 
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. | 
| 运输: | Room temperature in continental US; may vary elsewhere. | 
| 产品描述: | Halofuginone hydrobromide (RU-19110 hydrobromide) 是 Febrifugine 的一种低毒性衍生物,可从Dichroa febrifuga中分离出来。Halofuginone 是一种 ATP 竞争性的脯氨酰-tRNA 合成酶 (prolyl-tRNA synthetase) 抑制剂,Ki为 18.3 nM。Halofuginone 是 I 型胶原 (type-I collagen) 合成的特异性抑制剂,并通过抑制TGF-β活性可减轻骨关节炎。 | 
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: | 
McIntosh, L., et al.: Biochem. Cell Biol., 73, 181 (1995), Leshem, Y., et al.: Exp. Cell Res., 274, 288 (2002),